Cites del registre
Cita APA (7th ed.)
Barabanshchikova, M. V., Morozova, E. V., Vlasova, Y. Y., Baykov, V. V., Zubarovskaya, L. S., & Afanasyev, B. V. (2016). Application of inhibitor JAK1 and JAK2 ruxolitinib as pre- and posttransplant therapy in patients with myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Barabanshchikova, M. V., E. V. Morozova, Yu. Yu Vlasova, V. V. Baykov, L. S. Zubarovskaya, i B. V. Afanasyev. Application of Inhibitor JAK1 and JAK2 Ruxolitinib as Pre- and Posttransplant Therapy in Patients with Myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University, 2016.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Barabanshchikova, M. V., et al. Application of Inhibitor JAK1 and JAK2 Ruxolitinib as Pre- and Posttransplant Therapy in Patients with Myelofibrosis. Academician I.P. Pavlov First St. Petersburg State Medical University, 2016.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.